These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32611646)

  • 1. Association of guideline publication and delays to treatment in pediatric status epilepticus.
    Sánchez Fernández I; Abend NS; Amengual-Gual M; Anderson A; Arya R; Barcia Aguilar C; Brenton JN; Carpenter JL; Chapman KE; Clark J; Farias-Moeller R; Gaillard WD; Gaínza-Lein M; Glauser T; Goldstein J; Goodkin HP; Guerriero RM; Lai YC; McDonough T; Mikati MA; Morgan LA; Novotny E; Payne E; Peariso K; Piantino J; Ostendorf A; Sands TT; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian AA; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2020 Sep; 95(9):e1222-e1235. PubMed ID: 32611646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line medication dosing in pediatric refractory status epilepticus.
    Vasquez A; Gaínza-Lein M; Abend NS; Amengual-Gual M; Anderson A; Arya R; Brenton JN; Carpenter JL; Chapman K; Clark J; Farias-Moeller R; Gaillard WD; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Riviello JJ; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2020 Nov; 95(19):e2683-e2696. PubMed ID: 32913024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus.
    Sheehan T; Amengual-Gual M; Vasquez A; Abend NS; Anderson A; Appavu B; Arya R; Barcia Aguilar C; Brenton JN; Carpenter JL; Chapman KE; Clark J; Farias-Moeller R; Gaillard WD; Gaínza-Lein M; Glauser TA; Goldstein JL; Goodkin HP; Guerriero RM; Huh L; Jackson M; Kapur K; Kahoud R; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Reece L; Riviello JJ; Sands TT; Sannagowdara K; Shellhaas R; Smith G; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Zhang B; Loddenkemper T;
    Epilepsia; 2021 Nov; 62(11):2766-2777. PubMed ID: 34418087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.
    Gaínza-Lein M; Sánchez Fernández I; Jackson M; Abend NS; Arya R; Brenton JN; Carpenter JL; Chapman KE; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Kapur K; Mikati MA; Peariso K; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    JAMA Neurol; 2018 Apr; 75(4):410-418. PubMed ID: 29356811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children.
    Peariso K; Arya R; Glauser T; Abend NS; Barcia Aguilar C; Amengual-Gual M; Anderson A; Appavu BL; Brenton JN; Carpenter J; Chapman KE; Clark J; Gaillard WD; Gaínza-Lein M; Goldstein J; Goodkin H; Grinspan Z; Guerriero RM; Horn PS; Huh L; Kahoud R; Kelley SA; Kossoff EH; Kapur K; Lai YC; Marquis BO; McDonough T; Mikati MA; Morgan L; Novotny E; Ostendorf AP; Payne ET; Piantino J; Riviello J; Sands T; Stafstrom CE; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2023 Aug; 101(5):e546-e557. PubMed ID: 37295955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.
    Sánchez Fernández I; Jackson MC; Abend NS; Arya R; Brenton JN; Carpenter JL; Chapman KE; Gaillard WD; Gaínza-Lein M; Glauser TA; Goldstein JL; Goodkin HP; Helseth A; Kapur K; McDonough TL; Mikati MA; Peariso K; Riviello J; Tasker RC; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2017 Jan; 88(4):386-394. PubMed ID: 28011930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Treatment in Pediatric Convulsive Refractory Status Epilepticus: The Weekend Effect.
    Barcia Aguilar C; Amengual-Gual M; Sánchez Fernández I; Abend NS; Anderson A; Appavu B; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Farias-Moeller R; Gaillard WD; Gaínza-Lein M; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Huh L; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf A; Payne ET; Peariso K; Piantino J; Riviello J; Sannagowdara K; Sheehan T; Sands TT; Tasker RC; Tchapyjnikov D; Topjian AA; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Pediatr Neurol; 2021 Jul; 120():71-79. PubMed ID: 34022752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated identification and quality measurement for pediatric convulsive status epilepticus.
    Hess-Homeier DL; Parikh K; Basma N; Vella AE; Grinspan ZM
    Epilepsia; 2021 Feb; 62(2):337-346. PubMed ID: 33341928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers.
    Vasquez A; Gaínza-Lein M; Sánchez Fernández I; Abend NS; Anderson A; Brenton JN; Carpenter JL; Chapman K; Clark J; Gaillard WD; Glauser T; Goldstein J; Goodkin HP; Lai YC; Loddenkemper T; McDonough TL; Mikati MA; Nayak A; Payne E; Riviello J; Tchapyjnikov D; Topjian AA; Wainwright MS; Tasker RC;
    Pediatr Neurol; 2018 Sep; 86():33-41. PubMed ID: 30075875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Status Epilepticus: Treat Early and Avoid Delays.
    Morgan LA; Hrachovec JB; Goodkin HP
    Paediatr Drugs; 2023 Jul; 25(4):411-424. PubMed ID: 37178271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and selection of first antiseizure medication in patients with pediatric status epilepticus.
    Cohen NT; Chamberlain JM; Gaillard WD
    Epilepsy Res; 2019 Jan; 149():21-25. PubMed ID: 30445256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acute seizure and status epilepticus in pediatric emergency.
    Sasidaran K; Singhi S; Singhi P
    Indian J Pediatr; 2012 Apr; 79(4):510-7. PubMed ID: 22120613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with status epilepticus management protocol and effect on clinical outcomes in children with status epilepticus.
    Srivastava K; Suryawanshi VR; Yerrapalam N; Panda BK
    Eur J Hosp Pharm; 2023 May; 30(3):147-152. PubMed ID: 34183455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
    Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
    Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 17. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with long-term outcomes in pediatric refractory status epilepticus.
    Gaínza-Lein M; Barcia Aguilar C; Piantino J; Chapman KE; Sánchez Fernández I; Amengual-Gual M; Anderson A; Appavu B; Arya R; Brenton JN; Carpenter JL; Clark J; Farias-Moeller R; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Huh L; Kahoud R; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Nayak A; Novotny E; Ostendorf AP; Payne ET; Peariso K; Reece L; Riviello J; Sannagowdara K; Sands TT; Sheehan T; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Zhang B; Loddenkemper T;
    Epilepsia; 2021 Sep; 62(9):2190-2204. PubMed ID: 34251039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.